Kyowa Hakko Bio is an international health ingredients manufacturer and world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products. Kyowa Hakko U.S.A., Inc. (Kyowa Hakko USA) is a wholly owned subsidiary of Kyowa Hakko Bio Co., Ltd., headquartered in Tokyo, Japan.
Kyowa Hakko is the maker of self-affirmed GRAS approved offerings including:
• Cognizin® Citicoline, a multifunctional ingredient for functional food and beverage manufacturers looking to boost the brain health benefits of their products. With years of success in the dietary supplement industry, Cognizin Citicoline is backed by numerous scientific studies supporting claims of improved attention, recall and focus. Cognizin is also highly stable, ultra-pure and allergen-free.
• Sustamine™ L-Alanyl-L-Glutamine, an all-natural, highly absorbable ingredient designed to promote muscle rehydration and recovery. The only GRAS L-Alanyl-L-Glutamine ingredient available on the market, this "high-tech" amino acid is odorless, tasteless and extremely stable which makes it the perfect choice for functional beverage applications.
Kyowa Hakko Bio was the first company in the world to successfully produce and commercialize amino acids using fermentation methods, and over the years, the company has introduced more than 50 amino acids and related compounds. Kyowa Hakko has maintained a constant commitment to research, developing innovative products, processes and quality management. As a U.S. FDA-inspected manufacturer, Kyowa Hakko provides the industry with complete analytical information for all its products and maintains extensive manufacturing and R&D facilities in both the U.S. and Japan.